If you are in Medicare and also have healthcare coverage through a company or union retiree healthcare plan, this information is important for you.

Senate Finance Committee Chairman's White Paper Outlines Plans to Improve Healthcare Coverage While Launching New Initiatives to Improve Care Quality and Value WASHINGTON, Nov. 12 /PRNewswire-USNewswire/ -- US Oncology, which supports one of the ...

Health coverage for the family helps to assist those families in obtaining more affordable healthcare services, says a report by the Henry J. Kaiser Family Foundation. The Foundation, which based the report on its 2005 Low-Income Coverage and Access ...

This digital document is a journal article from Industrial Marketing Management, published by Elsevier in 2005. The article is delivered in HTML format and is available in your Amazon.com Media Library immediately after purchase. You can view it ...

BMI has upgraded its five-year value-growth forecast for the Mexican pharmaceutical market for 2007 - 2012 from an average rate of 5.5% per annum to 6.6%. Increased government spending and enabling legislation aimed to achieve earlier commitments to ...

BMI has upgraded its five-year value-growth forecast for the Mexican pharmaceutical market for 2007 - 2012 from an average rate of 5.5% per annum to 6.6%. Increased government spending and enabling legislation aimed to achieve earlier commitments to ...

Egypt's pharmaceutical market is a relatively unattractive prospect. Tough pricing regulation limit the market's potential, despite its size and government plans to roll out basic universal health coverage. In 2007, BMI estimates that drug ...

Egypt's pharmaceutical market is a relatively unattractive prospect. Tough pricing regulation limit the market's potential, despite its size and government plans to roll out basic universal health coverage. In 2007, BMI estimates that drug ...

Iran's pharmaceutical market was estimated to be worth US$1794mn in 2007, making it large in regional terms. However, per capita pharmaceutical consumption remains significantly lower than in many neighbouring Gulf states - standing at just US$25 in ...

Iran's pharmaceutical market was estimated to be worth US$1794mn in 2007, making it large in regional terms. However, per capita pharmaceutical consumption remains significantly lower than in many neighbouring Gulf states - standing at just US$25 in ...